Literature DB >> 16604306

alpha-Synuclein promoter RsaI T-to-C polymorphism and the risk of Parkinson's disease.

C K Wang1, C M Chen, C Y Chang, K H Chang, I C Chen, M L Li, G-J Lee-Chen, Y R Wu.   

Abstract

Increased alpha-synuclein expression may be involved in the pathogenesis of Parkinson's disease (PD). We investigated the association of Rep1 microsatellite and RsaI T-to-C substitution in the alpha-synuclein promoter region with the risk of PD by a case-control study. The RsaI C/C genotype and C allele were found less frequently in PD patients than in controls. A reduced risk of the Rep1-RsaI 0-C haplotype (OR = 0.57, 95% CI = 0.36-0.90) with PD was evident. The quantitative real-time PCR study showed that the alpha-synuclein mRNA expression was increased (although not significantly) in PD patients with RsaI T/T genotype or Rep1-RsaI 0-T haplotype as compared to T/C genotype or 0-C haplotype. Reporter constructs containing the RsaI C allele drove significantly lower transcriptional activity compared with the RsaI T allele in both IMR32 and 293 cells. The findings suggest that the RsaI T-to-C substitution may have a functional relevance to the susceptibility to PD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16604306     DOI: 10.1007/s00702-006-0435-4

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  29 in total

1.  Parkinson's disease is not associated with the combined alpha-synuclein/apolipoprotein E susceptibility genotype.

Authors:  N Khan; E Graham; P Dixon; C Morris; A Mander; D Clayton; J Vaughan; N Quinn; A Lees; S Daniel; N Wood; R de Silva
Journal:  Ann Neurol       Date:  2001-05       Impact factor: 10.422

2.  Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system.

Authors:  O Chiba-Falek; R L Nussbaum
Journal:  Hum Mol Genet       Date:  2001-12-15       Impact factor: 6.150

3.  Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.

Authors:  R Krüger; W Kuhn; T Müller; D Woitalla; M Graeber; S Kösel; H Przuntek; J T Epplen; L Schöls; O Riess
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

4.  Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation.

Authors:  L Narhi; S J Wood; S Steavenson; Y Jiang; G M Wu; D Anafi; S A Kaufman; F Martin; K Sitney; P Denis; J C Louis; J Wypych; A L Biere; M Citron
Journal:  J Biol Chem       Date:  1999-04-02       Impact factor: 5.157

5.  Multiple regions of alpha-synuclein are associated with Parkinson's disease.

Authors:  Jakob C Mueller; Julia Fuchs; Anne Hofer; Alexander Zimprich; Peter Lichtner; Thomas Illig; Daniela Berg; Ullrich Wüllner; Thomas Meitinger; Thomas Gasser
Journal:  Ann Neurol       Date:  2005-04       Impact factor: 10.422

6.  Alpha-synuclein expression in substantia nigra and cortex in Parkinson's disease.

Authors:  M Neystat; T Lynch; S Przedborski; N Kholodilov; M Rzhetskaya; R E Burke
Journal:  Mov Disord       Date:  1999-05       Impact factor: 10.338

7.  alpha-Synuclein gene haplotypes are associated with Parkinson's disease.

Authors:  M Farrer; D M Maraganore; P Lockhart; A Singleton; T G Lesnick; M de Andrade; A West; R de Silva; J Hardy; D Hernandez
Journal:  Hum Mol Genet       Date:  2001-08-15       Impact factor: 6.150

8.  alpha-Synuclein promoter confers susceptibility to Parkinson's disease.

Authors:  Philippe Pals; Sarah Lincoln; Jonathan Manning; Michael Heckman; Lisa Skipper; Mary Hulihan; Marleen Van den Broeck; Tim De Pooter; Patrick Cras; Julia Crook; Christine Van Broeckhoven; Matt J Farrer
Journal:  Ann Neurol       Date:  2004-10       Impact factor: 10.422

9.  Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease.

Authors:  P Ibáñez; A-M Bonnet; B Débarges; E Lohmann; F Tison; P Pollak; Y Agid; A Dürr; A Brice
Journal:  Lancet       Date:  2004 Sep 25-Oct 1       Impact factor: 79.321

10.  Alpha-synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication.

Authors:  D W Miller; S M Hague; J Clarimon; M Baptista; K Gwinn-Hardy; M R Cookson; A B Singleton
Journal:  Neurology       Date:  2004-05-25       Impact factor: 9.910

View more
  4 in total

1.  Mitochondrial DNA polymorphisms and the risk of Parkinson's disease in Taiwan.

Authors:  C M Chen; C C Kuan; G-J Lee-Chen; Y R Wu
Journal:  J Neural Transm (Vienna)       Date:  2007-03-15       Impact factor: 3.575

2.  Transcriptional dysregulation in a transgenic model of Parkinson disease.

Authors:  Talene A Yacoubian; Ippolita Cantuti-Castelvetri; Bérengère Bouzou; Georgios Asteris; Pamela J McLean; Bradley T Hyman; David G Standaert
Journal:  Neurobiol Dis       Date:  2007-11-28       Impact factor: 5.996

3.  Discovery of functional non-coding conserved regions in the α-synuclein gene locus.

Authors:  Lori Sterling; Michael Walter; Dennis Ting; Birgitt Schüle
Journal:  F1000Res       Date:  2014-10-29

Review 4.  The Emerging Role of the Lysosome in Parkinson's Disease.

Authors:  Alba Navarro-Romero; Marta Montpeyó; Marta Martinez-Vicente
Journal:  Cells       Date:  2020-11-02       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.